Category: NCMAG advice
NCMAG 127 Arsenic trioxide in combination with all-trans retinoic acid (ATRA [tretinoin]): July 2026
NCMAG 127 Arsenic trioxide in combination with all-trans retinoic acid (ATRA [tretinoin]): June 2026
NCMAG126 Nivolumab in combination with ipilimumab advice document: April 2026
NCMAG126 Nivolumab in combination with ipilimumab advice document: April 2026
NCMAG125 Paclitaxel advice document: January 2026
NCMAG125 Paclitaxel advice document: January 2026
NCMAG123 Bevacizumab advice document: July 2025
Summary Bevacizumab in combination with fluoropyrimidine-based chemotherapy for the first line treatment of adult patients with metastatic carcinoma of the […]
NCMAG124 Bevacizumab advice document: July 2025
NCMAG124 Bevacizumab advice document. Published July 2025
NCMAG123 Bevacizumab advice document: July 2025
NCMAG123 Bevacizumab advice document. Published July 2025
NCMAG121 Nivolumab in combination with ipilimumab advice document: April 2025
NCMAG121 Nivolumab in combination with ipilimumab advice document : April 2025
NCMAG122 Pembrolizumab advice document: April 2025
NCMAG122 Pembrolizumab advice document : April 2025
NCMAG119 Pomalidomide in combination with dexamethasone advice document: February 2025
NCMAG119 Pomalidomide in combination with dexamethasone advice document: February 2025